S
SBIO icon

SignatureFD’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

SignatureFD’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$5.7K – 3405
2025
Q1 		$5.7K Hold
200
– – ﹤0.01% 2553
2024
Q4 		$6.61K Hold
200
– – ﹤0.01% 2504
2024
Q3 		$7.47K Hold
200
– – ﹤0.01% 2452
2024
Q2 		$6.72K Hold
200
– – ﹤0.01% 2411
2024
Q1 		$7.15K Hold
200
– – ﹤0.01% 2428
2023
Q4 		$6.59K Hold
200
– – ﹤0.01% 2424
2023
Q3 		$5.44K Hold
200
– – ﹤0.01% 2458
2023
Q2 		$6.31K Hold
200
– – ﹤0.01% 2429
2023
Q1 		$5.44K Hold
200
– – ﹤0.01% 2477
2022
Q4 		$6.08K Hold
200
– – ﹤0.01% 2375
2022
Q3 		$6K Hold
200
– – ﹤0.01% 2374
2022
Q2 		$6K Sell
200
-200
-50% -$5.7K ﹤0.01% 2397
2022
Q1 		$13K Hold
400
– – ﹤0.01% 2051
2021
Q4 		$17K Hold
400
– – ﹤0.01% 1860
2021
Q3 		$18K Hold
400
– – ﹤0.01% 1816
2021
Q2 		$20K Hold
400
– – ﹤0.01% 1720
2021
Q1 		$20K Hold
400
– – ﹤0.01% 1579
2020
Q4 		$20K Buy
400
+200
+100% +$9.52K ﹤0.01% 1450
2020
Q3 		$8K Buy
+200
New +$8.25K ﹤0.01% 1740

Other funds holding SBIO

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SignatureFD's SBIO Position: Q2 2025 in Review

SignatureFD sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2025, closing a stake of 200 shares — an estimated $5.7K sold.

SignatureFD first reported a position in SBIO in Q3 2020 and held it in 19 quarters. The position peaked at $20K in Q2 2021. 36 funds tracked by Wall St. Rank hold SBIO as of Q2 2025.

  • SignatureFD reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 200 ALPS Medical Breakthroughs ETF shares in Q2 2025, an estimated $5.7K.
  • SignatureFD first reported a position in ALPS Medical Breakthroughs ETF in Q3 2020 and held it in 19 quarters.
  • SignatureFD's ALPS Medical Breakthroughs ETF position peaked at $20K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.